1. Optimizing the average distance between a blue light photosensitizer and a harmonic nanoparticle for effective infrared photodynamic therapy.
- Author
-
Barbora A, Lyssenko S, Amar M, Nave V, Zivan V, Argaev Frenkel L, Nause A, Cohen-Harazi R, and Minnes R
- Subjects
- Photosensitizing Agents pharmacology, Photosensitizing Agents therapeutic use, Infrared Rays, Photochemotherapy methods, Nanoparticles, Curcumin
- Abstract
Photodynamic therapy can be significantly improved by techniques utilizing light windows of higher tissue penetration depths with optimally matched photoactive agents to provide deep interstitial treatment. Classical blue light photosensitizers were photodynamically activated using infrared light via coupled harmonic nanoparticles with optimized intermediary distances using spacers. Upon 800 nm pulsed laser irradiation perovskite nanoparticles with optimized coupling to either curcumin or protoporphyrin IX reduced the viability of MCF7 breast cancer cells by 73 percent and 64 percent, respectively, while exhibiting negligible dark toxicity. The findings pave the way for clinical adaptation of ease-of-synthesis photodynamically active preparations operable under deep tissue penetrating infrared lights using commonly available otherwise infrared inactive classical blue light photosensitizers., Competing Interests: Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: [Refael Minnes has patent NEAR-INFRARED PHOTODYNAMIC THERAPY USING SECOND HARMONIC GENERATION NANOPARTICLE AND VISIBLE LIGHT REACTIVE PHOTOSENSITIZER pending to Refael Minnes and Ayan Barbora]., (Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.)
- Published
- 2023
- Full Text
- View/download PDF